|
Volumn 14, Issue 7, 2013, Pages 696-697
|
Regulation unmasked by activation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
CD24 ANTIGEN;
CD52 ANTIGEN;
SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN;
SIGLEC 10;
UNCLASSIFIED DRUG;
VASCULAR ADHESION PROTEIN 1;
ANTIGENICITY;
B LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CHRONIC LYMPHATIC LEUKEMIA;
ENZYME PHOSPHORYLATION;
EOSINOPHIL;
GRANULOCYTE;
HUMAN;
IMMUNE SYSTEM;
IN VITRO STUDY;
IN VIVO STUDY;
INNATE IMMUNITY;
LEUKOCYTE;
MOLECULE;
MONOCYTE;
MULTIPLE SCLEROSIS;
NATURAL KILLER CELL;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
REGULATORY MECHANISM;
REGULATORY T LYMPHOCYTE;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, NEOPLASM;
CD4-POSITIVE T-LYMPHOCYTES;
DIABETES MELLITUS, TYPE 1;
FEMALE;
GLYCOPROTEINS;
HUMANS;
LYMPHOCYTE ACTIVATION;
MALE;
SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS;
|
EID: 84879396986
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni.2646 Document Type: Note |
Times cited : (2)
|
References (10)
|